Optimizing Infarct Size by Transforming Emergent Stenting Into an Elective Procedure Study
Phase 4
- Conditions
- Myocardial Infarction
- Interventions
- Procedure: Immediate stentingProcedure: Delayed stenting
- First Posted Date
- 2011-10-31
- Last Posted Date
- 2011-10-31
- Lead Sponsor
- Marco Valgimigli
- Target Recruit Count
- 100
- Registration Number
- NCT01462188
- Locations
- 🇮🇹
U.O. Cardiologia, Ferrara, Emilia Romagna, Italy
Zotarolimus-eluting Endeavor Sprint Stent in Uncertain DES Candidates (ZEUS) Study
Phase 3
- Conditions
- Coronary Artery Disease
- Interventions
- Device: Bare metal stent implantationDevice: zotarolimus eluting stent
- First Posted Date
- 2011-06-30
- Last Posted Date
- 2012-10-10
- Lead Sponsor
- Marco Valgimigli
- Target Recruit Count
- 1606
- Registration Number
- NCT01385319
- Locations
- 🇵🇹
Hospital de Santa Cruz, Carnaxide, Portugal
🇨ðŸ‡University Hospital of Geneva, Geneva, Switzerland
🇮🇹Ospedale di Savigliano, Savigliano, CN, Italy
Synergy Between Stent and Drugs to Avoid Ischemic Recurrences After Percutaneous Coronary Intervention
Phase 4
Completed
- Conditions
- Coronary Artery Disease
- Interventions
- First Posted Date
- 2008-02-08
- Last Posted Date
- 2012-10-10
- Lead Sponsor
- Marco Valgimigli
- Target Recruit Count
- 1700
- Registration Number
- NCT00611286
- Locations
- 🇮🇹
Azienda Ospedaliera Universitaria di Ferrara, Ferrara, Emilia Romagna, Italy
Predictive Value of Allen's Test Result in Elective Patients Undergoing Coronary Catheterization Through Radial Approach
Phase 3
Completed
- Conditions
- Coronary Artery Disease
- Interventions
- Procedure: coronary catheterisation
- First Posted Date
- 2008-01-18
- Last Posted Date
- 2011-10-27
- Lead Sponsor
- Marco Valgimigli
- Target Recruit Count
- 203
- Registration Number
- NCT00597324
- Locations
- 🇮🇹
University Hospital, Ferrara, FE, Italy
Multicentre 2x2 Factorial Randomised Study Comparing Tirofiban Versus Abciximab and SES Versus BMS in AMI
Phase 4
- Conditions
- Myocardial Infarction
- Interventions
- Other: abciximab and Sirolimus eluting stentOther: tirofiban and bare metal stentOther: abciximab followed by implantation of bare metal stentOther: tirofiban and sirolimus-eluting stent
- First Posted Date
- 2005-09-29
- Last Posted Date
- 2011-10-27
- Lead Sponsor
- Marco Valgimigli
- Target Recruit Count
- 744
- Registration Number
- NCT00229515
- Locations
- 🇮🇹
Cattedra di Cardiologia, Azienda Ospedaliera Universitaria di Ferrara, Ferrara, Italy
© Copyright 2025. All Rights Reserved by MedPath